Pharmacological characterization of harmaline-induced tremor activity in mice

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 73-80

  Paterson, Neil E ^a   Malekiani, Sam A ^a   Foreman, Mark M ^a   Olivier, Berend ^a,b   Hanania, Taleen ^a  

^a PSYCHOGENICS INC   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Hydroxy butyrate; Carbamazepine; D1 receptor; D2 receptor; Dopamine; Essential tremor; GABA; Gabapentin; Glutamate; Harmaline; ICR mouse; Lithium; Primidone; Propranolol; Validity; Valproate

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 HYDROXYBUTYRIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; APOMORPHINE; BACLOFEN; CARBAMAZEPINE; CHLORDIAZEPOXIDE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GABAPENTIN; HARMALINE; IONOTROPIC RECEPTOR; LITHIUM SALT; MUSCIMOL; PHENCYCLIDINE; PRIMIDONE; PROPRANOLOL; QUINPIROLE; RACLOPRIDE; SEDATIVE AGENT; VALPROIC ACID; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL TREMOR; GABAERGIC SYSTEM; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL;

AFFECT; ANIMALS; ANTICONVULSANTS; BACLOFEN; BEHAVIOR, ANIMAL; BENZAZEPINES; CARBOLINES; CHLORDIAZEPOXIDE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; HARMALINE; LITHIUM CHLORIDE; MALE; MICE; MICE, INBRED ICR; MUSCIMOL; NEUROTRANSMITTER AGENTS; PIPERAZINES; PROPRANOLOL; RACLOPRIDE; RECEPTORS, GLUTAMATE; SODIUM OXYBATE; TREMOR;

EID: 67651108751     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.05.031     Document Type: Article

References (71)

1. Ahmed A., and Taylor N. Analysis of drug-induced tremor in mice. Br. J. Pharmacol. 14 (1959) 350-354
2. Ahmad S., Fowler L.J., and Whitton P.S. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats. Naunyn Schmiedebergs Arch. Pharmacol. 371 (2005) 1-8
3. Antonelli T., Ferioli V., Lo Gallo G., Tomasini M.C., Fernandez M., O'Connor W.T., Glennon J.C., Tanganelli S., and Ferraro L. Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat. Synapse 38 (2000) 355-362
4. Audinat E., Knopfel T., and Gahwiler B.H. Responses to excitatory amino acids of Purkinje cells and neurons of the deep nuclei in cerebellar slice cultures. J. Physiol. 430 (1990) 297-313
5. Berton F., Brancucci A., Beghè F., Cammalleri M., Demuro A., Francesconi W., and Gessa G.L. Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. Eur. J. Pharmacol. 380 (1999) 109-116
6. Bilak S.R., Bilak M.M., and Morest D.K. NMDA receptor expression in the mouse cerebellar cortex. Synapse 20 (1995) 257-268
7. Blair M.A., Ma S., Phibbs F., Fang J.Y., Cooper M.K., Davis T.L., and Hedera P. Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism Relat. Disord. 14 (2008) 471-475
8. Cai Z., and McCaslin P.P. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-d-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur. J. Pharmacol. 219 (1992) 53-57
9. Calabresi P., Centonze D., Marfia G.A., Pisani A., and Bernardi G. An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. Br. J. Pharmacol. 126 (1999) 689-696
10. Carai M.A., Colombo G., Brunetti G., Melis S., Serra S., Vacca G., Mastinu S., Pistuddi A.M., Solinas C., Minardi G., and Gessa G.L. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur. J. Pharmacol. 428 (2001) 315-321
11. Chang C.C., Luntz-Leybman V., Evans J.E., Rotter A., and Frostholm A. Developmental changes in the expression of gamma-aminobutyric acidA/benzodiazepine receptor subunit mRNAs in the murine inferior olivary complex. J. Comp. Neurol. 356 (1995) 615-628
12. Chen L.W., Tse Y.C., Li C., Guan Z.L., Lai C.H., Yung K.K., Shum D.K., and Chan Y.S. Differential expression of NMDA and AMPA/KA receptor subunits in the inferior olive of postnatal rats. Brain Res. 1067 (2006) 103-114
13. Cross A.J., Misra A., Sandilands A.M., Taylor M.J., and Green A.R. Effect of chlormethiazole, dizocilpine and pentobarbital on harmaline-induced increase of cerebellar cyclic GMP and tremor. Psychopharmacology 111 (1993) 96-98
14. B receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J. Pharmacol. Exp. Ther. 310 (2004) 952-963
15. De Zeeuw C.I., Simpson J.I., Hoogenraad C.C., Galjart N., Koekkoek S.K.E., and Ruigrok T.J.H. Microcircuitry and function of the inferior olive. Trends Neurosci. 21 (1998) 391-400
16. Deng H., Le W., and Jankovic J. Genetics of essential tremor. Brain 130 (2007) 1456-1464
17. Du W., and Harvey J.A. Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit. Brain Res. 745 (1997) 183-188
18. Du W., Aloyo V.J., and Harvey J.A. Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Brain Res. 770 (1997) 26-29
19. Eblen F., Loschmann P.A., Wullner U., Turski L., and Klockgether T. Effects of 7-nitroindazole, NG-nitro-l-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-d-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eur. J. Pharmacol. 299 (1996) 9-16
20. Fink K., Meder W., Dooley D.J., and Göthert M. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br. J. Pharmacol. 130 (2000) 900-906
21. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., and Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 107 (2001) 107-124
22. 2 dopamine receptor knockout mice. Int. J. Dev. Neurosci. 20 (2002) 309-321
23. Frostholm A., Zdilar D., Luntz-Leybman V., Janapati V., and Rotter A. Ontogeny of GABAA/benzodiazepine receptor subunit mRNAs in the murine inferior olive: transient appearance of beta 3 subunit mRNA and [3H]muscimol binding sites. Brain Res. Mol. Brain Res. 16 (1992) 246-254
24. Frucht S.J., Houghton W.C., Bordelon Y., Greene P.E., and Louis E.D. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology 65 (2005) 1967-1969
25. Gelenberg A.J., and Jefferson J.W. Lithium tremor. J Clin Psychiatry 56 (1995) 283-287
26. Gironell A. Therapeutic strategies for essential tremor. Med. Clin. (Barc.) 129 (2007) 632-637
27. Gobbi G., and Janiri L. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology (Berl) 185 (2006) 255-262
28. Goldman M.E., and Kebabian J.W. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors. Mol. Pharmacol. 25 (1984) 18-23
29. Götz E., Feuerstein T.J., Lais A., and Meyer D.K. Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 43 (1993) 636-638
30. Higgins J.J., Loveless J.M., Jankovic J., and Patel P.I. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov. Disord. 13 (1998) 972-977
31. Hutchinson D., Ho V., Dodd M., Dawson H.N., Zumwalt A.C., Schmitt D., and Colton C.A. Quantitative measurement of postural sway in mouse models of human neurodegenerative disease. Neuroscience 148 (2007) 825-832
32. Isaias I.U., Canesi M., Benti R., Gerundini P., Cilia R., Pezzoli G., and Antonini A. Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl. Med. Commun. 29 (2008) 349-353
33. Jankovic J., and Noebels J.L. Genetic mouse models of essential tremor: are they essential? J. Clin. Invest. 115 (2005) 584-586
34. 3 receptor is associated with risk and age-at-onset of essential tremor. Proc. Natl. Acad. Sci. 103 (2006) 10753-10758
35. Jenkins I.H., Bain P.G., Colebatch J.G., Thompson P.D., Findley L.J., Frackowiak R.S., Marsden C.D., and Brooks D.J. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann. Neurol. 34 (1993) 82-90
36. Kashihara K., Okumura K., Onishi M., and Otsuki S. MK-801 fails to modify the effect of methamphetamine on dopamine release in the rat striatum. Neuroreport 2 (1991) 236-238
37. Kaupmann K., Cryan J.F., Wellendorph P., Mombereau C., Sansig G., Klebs K., Schmutz M., Froestl W., van der Putten H., Mosbacher J., Brauner-Osborne H., Waldmeier P., and Bettler B. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur. J. Neurosci. 8 (2003) 2722-2730
38. Kralic J.E., Criswell H.E., Osterman J.L., O'Buckley T.K., Wilkie M.E., Matthews D.B., Hamre K., Breese G.R., Homanics G.E., and Morrow A.L. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J. Clin. Invest. 115 (2005) 774-779
39. Lang E.J. GABAergic and glutamatergic modulation of spontaneous and motor-cortex-evoked complex spike activity. J. Neurophysiol. 87 (2002) 1993-2008
40. Li Q., Kuhn C.M., Wilson W.A., and Lewis D.V. Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex. Neuroscience 150 (2007) 82-92
41. Lorenz D., and Deuschl G. Update on pathogenesis and treatment of essential tremor. Curr. Opin. Neurol. 20 (2007) 447-452
42. Löscher W., Vetter M., Böhme G., and Stoltenburg-Didinger G. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat. J. Neural Transm. 63 (1985) 157-167
43. Lyons K.E., and Pahwa R. Pharmacotherapy of essential tremor: an overview of existing and upcoming agents. CNS Drugs 22 (2008) 1037-1045
44. Málly J., Baranyi M., and Vizi E.S. Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J. Neural Transm. Gen. Sect. 103 (1996) 555-560
45. Martin F.C., Thu Le A., and Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov. Disord. 20 (2005) 298-305
46. Mao C.C., Guidotti A., and Costa E. Inhibition by diazepam of the tremor and the increase of cerebellar cGMD content elicited by harmaline. Brain Res. 83 (1975) 516-519
47. Milner T.E., Cadoret T.E., Lessard L., and Smith A.M. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive. J. Neurophysiol. 73 (1995) 2568-2577
48. Miwa H. Rodent models of tremor. Cerebellum 6 (2007) 66-72
49. Miwa H., Kubo T., Suzuki A., Kihira T., and Kondo T. A species-specific difference in the effects of harmaline on the rodent olivocerebellar system. Brain Res. 1068 (2006) 94-101
50. Nagaki S., Kato N., Minatogawa Y., and Higuchi T. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain. Life Sci. 46 (1990) 1587-1595
51. National Institutes of Health. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
52. O'Donnell T., Rotzinger S., Ulrich M., Hanstock C.C., Nakashima T.T., and Silverstone P.H. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids. Eur. Neuropsychopharmacol. 13 (2003) 220-227
53. Otero Losada M.E., and Rubio M.C. Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex. Naunyn Schmiedebergs Arch. Pharmacol. 332 (1986) 169-172
54. Paarmann I., Frermann D., Keller B.U., and Hollmann M. Expression of 15 glutamate receptor subunits and various splice variants in tissue slices and single neurons of brainstem nuclei and potential functional implications. J. Neurochem. 74 (2000) 1335-1345
55. Peng X.Q., Li X., Li J., Ramachandran P.V., Gagare P.D., Pratihar D., Ashby Jr. C.R., Gardner E.L., and Xi Z.X. Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats. Drug Alcohol Depend. 97 (2008) 207-215
56. Petralia R.S., Sans N., Wang Y.X., Vissel B., Chang B., Noben-Trauth K., Heinemann S.F., and Wenthold R.J. Loss of GLUR2 alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor subunit differentially affects remaining synaptic glutamate receptors in cerebellum and cochlear nuclei. Eur. J. Neurosci. 19 (2004) 2017-2029
57. Rinnerthaler M., Luef G., Mueller J., Seppi K., Wissel J., Trinka E., Bauer G., and Poewe W. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Epilepsia 46 (2005) 320-323
58. Saano V., Tacke U., Sopanen L., and Airaksinen M.M. Tofizopam enhances the action of diazepam against tremor and convulsions. Med. Biol. 61 (1983) 49-53
59. Schweri M., Cain M., Cook J., Paul S., and Skilnick P. Blockade of 3-carbomethoxy-beta-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS 8216. Pharmacol. Biochem. Behav. 17 (1982) 457-460
60. Shinozaki H. Quantitative analysis of drug-induced tremor in mice. Neurosci. Res. 2 (1984) 63-76
61. Shinozaki H., Hirate K., and Ishida M. Further studies on quantification of drug-induced tremor in mice: effects of antitremorgenic agents on tremor frequency. Exp. Neurol. 88 (1985) 303-315
62. Sitges M., Guarneros A., and Nekrassov V. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 53 (2007) 854-862
63. Steinpreis R.E., and Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612 (1993) 263-270
64. Tariq M., Arshahuddin M., Biary N., Al Moutaery K., and Al Deeb S. Baclofen attenuates harmaline induced tremors in rats. Neurosci. Lett. 312 (2001) 79-82
65. Timmerman W., Bouma M., De Vries J.B., Davis M., and Westerink B.H. A microdialysis study on the mechanism of action of gabapentin. Eur. J. Pharmacol. 398 (2000) 53-57
66. Tolosa E.S., and Loewenson R.B. Essential tremor: treatment with propranolol. Neurology 25 (1975) 1041-1044
67. Uitti R.J. Medical treatment of essential tremor and Parkinson's disease. Geriatrics 53 (1998) 46-48
68. Vargas C., Tannhauser M., and Barros H.M. Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid. Gen. Pharmacol. 30 (1998) 601-604
69. Vitale C., Gulli R., Ciotti P., Scaglione C., Bellone E., Avanzino L., Lantieri F., Abbruzzese G., Martinelli P., Barone P., and Mandich P. DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. Eur. J. Neurol. 15 (2008) 985-987
70. Yoshida S., Okada M., Zhu G., and Kaneko S. Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor. Neuropharmacology 52 (2007) 1538-1546
71. Zeise M.L., Kasparow S., and Zieglgänsberger W. Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res. 544 (1991) 345-348